Outcomes of patients undergoing pancreatic surveillance for BRCA2 and ATMG mutations

This study evaluated the outcomes of patients with germline mutations in the BRCA2 and ATM genes who underwent screening for pancreatic cancer. The outcomes of these patients were compared between mutations, and those who developed pancreatic cancer over the course of screening were compared to those with the same mutations who developed pancreatic cancer but had not undergone screening.